Global Hormonal Transdermal Patches Market Insights, Forecast to 2029
This report presents an overview of global market for Hormonal Transdermal Patches, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Hormonal Transdermal Patches, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Hormonal Transdermal Patches, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hormonal Transdermal Patches sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Hormonal Transdermal Patches market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Hormonal Transdermal Patches sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hormonal Transdermal Patches in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Hormonal Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hormonal Transdermal Patches sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Hormonal Transdermal Patches, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Hormonal Transdermal Patches, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hormonal Transdermal Patches sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Hormonal Transdermal Patches market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Hormonal Transdermal Patches sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc.
By Company
- Xulane
- Twirla
- Planned Parenthood
- Lvye Pharma
- Novartis
- Bayer Healthcare Pharmaceuticals
- Watson Labs
- Women First Healthcare Inc
- Noven
- AbbVie
- Lumara Health
- ANI Pharmaceuticals
- Contraceptive Patches
- Estradiol Patches
- Others
- Hospital
- Clinic
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hormonal Transdermal Patches in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Hormonal Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hormonal Transdermal Patches sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Hormonal Transdermal Patches Product Introduction
1.2 Market by Type
1.2.1 Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Contraceptive Patches
1.2.3 Estradiol Patches
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hormonal Transdermal Patches Sales Estimates and Forecasts 2018-2029
2.2 Global Hormonal Transdermal Patches Revenue by Region
2.2.1 Global Hormonal Transdermal Patches Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hormonal Transdermal Patches Revenue by Region (2018-2023)
2.2.3 Global Hormonal Transdermal Patches Revenue by Region (2024-2029)
2.2.4 Global Hormonal Transdermal Patches Revenue Market Share by Region (2018-2029)
2.3 Global Hormonal Transdermal Patches Sales Estimates and Forecasts 2018-2029
2.4 Global Hormonal Transdermal Patches Sales by Region
2.4.1 Global Hormonal Transdermal Patches Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hormonal Transdermal Patches Sales by Region (2018-2023)
2.4.3 Global Hormonal Transdermal Patches Sales by Region (2024-2029)
2.4.4 Global Hormonal Transdermal Patches Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Hormonal Transdermal Patches Sales by Manufacturers
3.1.1 Global Hormonal Transdermal Patches Sales by Manufacturers (2018-2023)
3.1.2 Global Hormonal Transdermal Patches Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hormonal Transdermal Patches in 2022
3.2 Global Hormonal Transdermal Patches Revenue by Manufacturers
3.2.1 Global Hormonal Transdermal Patches Revenue by Manufacturers (2018-2023)
3.2.2 Global Hormonal Transdermal Patches Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Hormonal Transdermal Patches Revenue in 2022
3.3 Global Key Players of Hormonal Transdermal Patches, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Hormonal Transdermal Patches Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hormonal Transdermal Patches, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hormonal Transdermal Patches, Product Offered and Application
3.8 Global Key Manufacturers of Hormonal Transdermal Patches, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Hormonal Transdermal Patches Sales by Type
4.1.1 Global Hormonal Transdermal Patches Historical Sales by Type (2018-2023)
4.1.2 Global Hormonal Transdermal Patches Forecasted Sales by Type (2024-2029)
4.1.3 Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
4.2 Global Hormonal Transdermal Patches Revenue by Type
4.2.1 Global Hormonal Transdermal Patches Historical Revenue by Type (2018-2023)
4.2.2 Global Hormonal Transdermal Patches Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
4.3 Global Hormonal Transdermal Patches Price by Type
4.3.1 Global Hormonal Transdermal Patches Price by Type (2018-2023)
4.3.2 Global Hormonal Transdermal Patches Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Hormonal Transdermal Patches Sales by Application
5.1.1 Global Hormonal Transdermal Patches Historical Sales by Application (2018-2023)
5.1.2 Global Hormonal Transdermal Patches Forecasted Sales by Application (2024-2029)
5.1.3 Global Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
5.2 Global Hormonal Transdermal Patches Revenue by Application
5.2.1 Global Hormonal Transdermal Patches Historical Revenue by Application (2018-2023)
5.2.2 Global Hormonal Transdermal Patches Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
5.3 Global Hormonal Transdermal Patches Price by Application
5.3.1 Global Hormonal Transdermal Patches Price by Application (2018-2023)
5.3.2 Global Hormonal Transdermal Patches Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Hormonal Transdermal Patches Market Size by Type
6.1.1 US & Canada Hormonal Transdermal Patches Sales by Type (2018-2029)
6.1.2 US & Canada Hormonal Transdermal Patches Revenue by Type (2018-2029)
6.2 US & Canada Hormonal Transdermal Patches Market Size by Application
6.2.1 US & Canada Hormonal Transdermal Patches Sales by Application (2018-2029)
6.2.2 US & Canada Hormonal Transdermal Patches Revenue by Application (2018-2029)
6.3 US & Canada Hormonal Transdermal Patches Market Size by Country
6.3.1 US & Canada Hormonal Transdermal Patches Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hormonal Transdermal Patches Sales by Country (2018-2029)
6.3.3 US & Canada Hormonal Transdermal Patches Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Hormonal Transdermal Patches Market Size by Type
7.1.1 Europe Hormonal Transdermal Patches Sales by Type (2018-2029)
7.1.2 Europe Hormonal Transdermal Patches Revenue by Type (2018-2029)
7.2 Europe Hormonal Transdermal Patches Market Size by Application
7.2.1 Europe Hormonal Transdermal Patches Sales by Application (2018-2029)
7.2.2 Europe Hormonal Transdermal Patches Revenue by Application (2018-2029)
7.3 Europe Hormonal Transdermal Patches Market Size by Country
7.3.1 Europe Hormonal Transdermal Patches Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hormonal Transdermal Patches Sales by Country (2018-2029)
7.3.3 Europe Hormonal Transdermal Patches Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Hormonal Transdermal Patches Market Size
8.1.1 China Hormonal Transdermal Patches Sales (2018-2029)
8.1.2 China Hormonal Transdermal Patches Revenue (2018-2029)
8.2 China Hormonal Transdermal Patches Market Size by Application
8.2.1 China Hormonal Transdermal Patches Sales by Application (2018-2029)
8.2.2 China Hormonal Transdermal Patches Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Hormonal Transdermal Patches Market Size by Type
9.1.1 Asia Hormonal Transdermal Patches Sales by Type (2018-2029)
9.1.2 Asia Hormonal Transdermal Patches Revenue by Type (2018-2029)
9.2 Asia Hormonal Transdermal Patches Market Size by Application
9.2.1 Asia Hormonal Transdermal Patches Sales by Application (2018-2029)
9.2.2 Asia Hormonal Transdermal Patches Revenue by Application (2018-2029)
9.3 Asia Hormonal Transdermal Patches Sales by Region
9.3.1 Asia Hormonal Transdermal Patches Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hormonal Transdermal Patches Revenue by Region (2018-2029)
9.3.3 Asia Hormonal Transdermal Patches Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Market Size by Type
10.1.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Market Size by Application
10.2.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country
10.3.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Xulane
11.1.1 Xulane Company Information
11.1.2 Xulane Overview
11.1.3 Xulane Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Xulane Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Xulane Recent Developments
11.2 Twirla
11.2.1 Twirla Company Information
11.2.2 Twirla Overview
11.2.3 Twirla Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Twirla Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Twirla Recent Developments
11.3 Planned Parenthood
11.3.1 Planned Parenthood Company Information
11.3.2 Planned Parenthood Overview
11.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Planned Parenthood Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Planned Parenthood Recent Developments
11.4 Lvye Pharma
11.4.1 Lvye Pharma Company Information
11.4.2 Lvye Pharma Overview
11.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Lvye Pharma Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lvye Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Novartis Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Bayer Healthcare Pharmaceuticals
11.6.1 Bayer Healthcare Pharmaceuticals Company Information
11.6.2 Bayer Healthcare Pharmaceuticals Overview
11.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Healthcare Pharmaceuticals Recent Developments
11.7 Watson Labs
11.7.1 Watson Labs Company Information
11.7.2 Watson Labs Overview
11.7.3 Watson Labs Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Watson Labs Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Watson Labs Recent Developments
11.8 Women First Healthcare Inc
11.8.1 Women First Healthcare Inc Company Information
11.8.2 Women First Healthcare Inc Overview
11.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Women First Healthcare Inc Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Women First Healthcare Inc Recent Developments
11.9 Noven
11.9.1 Noven Company Information
11.9.2 Noven Overview
11.9.3 Noven Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Noven Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Noven Recent Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 AbbVie Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie Recent Developments
11.11 Lumara Health
11.11.1 Lumara Health Company Information
11.11.2 Lumara Health Overview
11.11.3 Lumara Health Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Lumara Health Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lumara Health Recent Developments
11.12 ANI Pharmaceuticals
11.12.1 ANI Pharmaceuticals Company Information
11.12.2 ANI Pharmaceuticals Overview
11.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 ANI Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ANI Pharmaceuticals Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Hormonal Transdermal Patches Industry Chain Analysis
12.2 Hormonal Transdermal Patches Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormonal Transdermal Patches Production Mode & Process
12.4 Hormonal Transdermal Patches Sales and Marketing
12.4.1 Hormonal Transdermal Patches Sales Channels
12.4.2 Hormonal Transdermal Patches Distributors
12.5 Hormonal Transdermal Patches Customers
13 MARKET DYNAMICS
13.1 Hormonal Transdermal Patches Industry Trends
13.2 Hormonal Transdermal Patches Market Drivers
13.3 Hormonal Transdermal Patches Market Challenges
13.4 Hormonal Transdermal Patches Market Restraints
14 KEY FINDINGS IN THE GLOBAL HORMONAL TRANSDERMAL PATCHES STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Hormonal Transdermal Patches Product Introduction
1.2 Market by Type
1.2.1 Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Contraceptive Patches
1.2.3 Estradiol Patches
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hormonal Transdermal Patches Sales Estimates and Forecasts 2018-2029
2.2 Global Hormonal Transdermal Patches Revenue by Region
2.2.1 Global Hormonal Transdermal Patches Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hormonal Transdermal Patches Revenue by Region (2018-2023)
2.2.3 Global Hormonal Transdermal Patches Revenue by Region (2024-2029)
2.2.4 Global Hormonal Transdermal Patches Revenue Market Share by Region (2018-2029)
2.3 Global Hormonal Transdermal Patches Sales Estimates and Forecasts 2018-2029
2.4 Global Hormonal Transdermal Patches Sales by Region
2.4.1 Global Hormonal Transdermal Patches Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hormonal Transdermal Patches Sales by Region (2018-2023)
2.4.3 Global Hormonal Transdermal Patches Sales by Region (2024-2029)
2.4.4 Global Hormonal Transdermal Patches Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Hormonal Transdermal Patches Sales by Manufacturers
3.1.1 Global Hormonal Transdermal Patches Sales by Manufacturers (2018-2023)
3.1.2 Global Hormonal Transdermal Patches Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hormonal Transdermal Patches in 2022
3.2 Global Hormonal Transdermal Patches Revenue by Manufacturers
3.2.1 Global Hormonal Transdermal Patches Revenue by Manufacturers (2018-2023)
3.2.2 Global Hormonal Transdermal Patches Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Hormonal Transdermal Patches Revenue in 2022
3.3 Global Key Players of Hormonal Transdermal Patches, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Hormonal Transdermal Patches Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hormonal Transdermal Patches, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hormonal Transdermal Patches, Product Offered and Application
3.8 Global Key Manufacturers of Hormonal Transdermal Patches, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Hormonal Transdermal Patches Sales by Type
4.1.1 Global Hormonal Transdermal Patches Historical Sales by Type (2018-2023)
4.1.2 Global Hormonal Transdermal Patches Forecasted Sales by Type (2024-2029)
4.1.3 Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
4.2 Global Hormonal Transdermal Patches Revenue by Type
4.2.1 Global Hormonal Transdermal Patches Historical Revenue by Type (2018-2023)
4.2.2 Global Hormonal Transdermal Patches Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
4.3 Global Hormonal Transdermal Patches Price by Type
4.3.1 Global Hormonal Transdermal Patches Price by Type (2018-2023)
4.3.2 Global Hormonal Transdermal Patches Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Hormonal Transdermal Patches Sales by Application
5.1.1 Global Hormonal Transdermal Patches Historical Sales by Application (2018-2023)
5.1.2 Global Hormonal Transdermal Patches Forecasted Sales by Application (2024-2029)
5.1.3 Global Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
5.2 Global Hormonal Transdermal Patches Revenue by Application
5.2.1 Global Hormonal Transdermal Patches Historical Revenue by Application (2018-2023)
5.2.2 Global Hormonal Transdermal Patches Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
5.3 Global Hormonal Transdermal Patches Price by Application
5.3.1 Global Hormonal Transdermal Patches Price by Application (2018-2023)
5.3.2 Global Hormonal Transdermal Patches Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Hormonal Transdermal Patches Market Size by Type
6.1.1 US & Canada Hormonal Transdermal Patches Sales by Type (2018-2029)
6.1.2 US & Canada Hormonal Transdermal Patches Revenue by Type (2018-2029)
6.2 US & Canada Hormonal Transdermal Patches Market Size by Application
6.2.1 US & Canada Hormonal Transdermal Patches Sales by Application (2018-2029)
6.2.2 US & Canada Hormonal Transdermal Patches Revenue by Application (2018-2029)
6.3 US & Canada Hormonal Transdermal Patches Market Size by Country
6.3.1 US & Canada Hormonal Transdermal Patches Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hormonal Transdermal Patches Sales by Country (2018-2029)
6.3.3 US & Canada Hormonal Transdermal Patches Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Hormonal Transdermal Patches Market Size by Type
7.1.1 Europe Hormonal Transdermal Patches Sales by Type (2018-2029)
7.1.2 Europe Hormonal Transdermal Patches Revenue by Type (2018-2029)
7.2 Europe Hormonal Transdermal Patches Market Size by Application
7.2.1 Europe Hormonal Transdermal Patches Sales by Application (2018-2029)
7.2.2 Europe Hormonal Transdermal Patches Revenue by Application (2018-2029)
7.3 Europe Hormonal Transdermal Patches Market Size by Country
7.3.1 Europe Hormonal Transdermal Patches Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hormonal Transdermal Patches Sales by Country (2018-2029)
7.3.3 Europe Hormonal Transdermal Patches Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Hormonal Transdermal Patches Market Size
8.1.1 China Hormonal Transdermal Patches Sales (2018-2029)
8.1.2 China Hormonal Transdermal Patches Revenue (2018-2029)
8.2 China Hormonal Transdermal Patches Market Size by Application
8.2.1 China Hormonal Transdermal Patches Sales by Application (2018-2029)
8.2.2 China Hormonal Transdermal Patches Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Hormonal Transdermal Patches Market Size by Type
9.1.1 Asia Hormonal Transdermal Patches Sales by Type (2018-2029)
9.1.2 Asia Hormonal Transdermal Patches Revenue by Type (2018-2029)
9.2 Asia Hormonal Transdermal Patches Market Size by Application
9.2.1 Asia Hormonal Transdermal Patches Sales by Application (2018-2029)
9.2.2 Asia Hormonal Transdermal Patches Revenue by Application (2018-2029)
9.3 Asia Hormonal Transdermal Patches Sales by Region
9.3.1 Asia Hormonal Transdermal Patches Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hormonal Transdermal Patches Revenue by Region (2018-2029)
9.3.3 Asia Hormonal Transdermal Patches Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Market Size by Type
10.1.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Market Size by Application
10.2.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country
10.3.1 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Xulane
11.1.1 Xulane Company Information
11.1.2 Xulane Overview
11.1.3 Xulane Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Xulane Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Xulane Recent Developments
11.2 Twirla
11.2.1 Twirla Company Information
11.2.2 Twirla Overview
11.2.3 Twirla Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Twirla Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Twirla Recent Developments
11.3 Planned Parenthood
11.3.1 Planned Parenthood Company Information
11.3.2 Planned Parenthood Overview
11.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Planned Parenthood Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Planned Parenthood Recent Developments
11.4 Lvye Pharma
11.4.1 Lvye Pharma Company Information
11.4.2 Lvye Pharma Overview
11.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Lvye Pharma Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lvye Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Novartis Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Bayer Healthcare Pharmaceuticals
11.6.1 Bayer Healthcare Pharmaceuticals Company Information
11.6.2 Bayer Healthcare Pharmaceuticals Overview
11.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Healthcare Pharmaceuticals Recent Developments
11.7 Watson Labs
11.7.1 Watson Labs Company Information
11.7.2 Watson Labs Overview
11.7.3 Watson Labs Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Watson Labs Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Watson Labs Recent Developments
11.8 Women First Healthcare Inc
11.8.1 Women First Healthcare Inc Company Information
11.8.2 Women First Healthcare Inc Overview
11.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Women First Healthcare Inc Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Women First Healthcare Inc Recent Developments
11.9 Noven
11.9.1 Noven Company Information
11.9.2 Noven Overview
11.9.3 Noven Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Noven Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Noven Recent Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 AbbVie Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie Recent Developments
11.11 Lumara Health
11.11.1 Lumara Health Company Information
11.11.2 Lumara Health Overview
11.11.3 Lumara Health Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Lumara Health Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lumara Health Recent Developments
11.12 ANI Pharmaceuticals
11.12.1 ANI Pharmaceuticals Company Information
11.12.2 ANI Pharmaceuticals Overview
11.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 ANI Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ANI Pharmaceuticals Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Hormonal Transdermal Patches Industry Chain Analysis
12.2 Hormonal Transdermal Patches Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormonal Transdermal Patches Production Mode & Process
12.4 Hormonal Transdermal Patches Sales and Marketing
12.4.1 Hormonal Transdermal Patches Sales Channels
12.4.2 Hormonal Transdermal Patches Distributors
12.5 Hormonal Transdermal Patches Customers
13 MARKET DYNAMICS
13.1 Hormonal Transdermal Patches Industry Trends
13.2 Hormonal Transdermal Patches Market Drivers
13.3 Hormonal Transdermal Patches Market Challenges
13.4 Hormonal Transdermal Patches Market Restraints
14 KEY FINDINGS IN THE GLOBAL HORMONAL TRANSDERMAL PATCHES STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Contraceptive Patches
Table 3. Major Manufacturers of Estradiol Patches
Table 4. Major Manufacturers of Others
Table 5. Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Hormonal Transdermal Patches Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Hormonal Transdermal Patches Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Hormonal Transdermal Patches Revenue Market Share by Region (2018-2023)
Table 10. Global Hormonal Transdermal Patches Revenue Market Share by Region (2024-2029)
Table 11. Global Hormonal Transdermal Patches Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Hormonal Transdermal Patches Sales by Region (2018-2023) & (K Units)
Table 13. Global Hormonal Transdermal Patches Sales by Region (2024-2029) & (K Units)
Table 14. Global Hormonal Transdermal Patches Sales Market Share by Region (2018-2023)
Table 15. Global Hormonal Transdermal Patches Sales Market Share by Region (2024-2029)
Table 16. Global Hormonal Transdermal Patches Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global Hormonal Transdermal Patches Sales Share by Manufacturers (2018-2023)
Table 18. Global Hormonal Transdermal Patches Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Hormonal Transdermal Patches Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Hormonal Transdermal Patches, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Hormonal Transdermal Patches Price by Manufacturers 2018-2023 (US$/Unit)
Table 22. Global Hormonal Transdermal Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Hormonal Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Transdermal Patches as of 2022)
Table 24. Global Key Manufacturers of Hormonal Transdermal Patches, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Hormonal Transdermal Patches, Product Offered and Application
Table 26. Global Key Manufacturers of Hormonal Transdermal Patches, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 29. Global Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 30. Global Hormonal Transdermal Patches Sales Share by Type (2018-2023)
Table 31. Global Hormonal Transdermal Patches Sales Share by Type (2024-2029)
Table 32. Global Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Hormonal Transdermal Patches Revenue Share by Type (2018-2023)
Table 35. Global Hormonal Transdermal Patches Revenue Share by Type (2024-2029)
Table 36. Hormonal Transdermal Patches Price by Type (2018-2023) & (US$/Unit)
Table 37. Global Hormonal Transdermal Patches Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 39. Global Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 40. Global Hormonal Transdermal Patches Sales Share by Application (2018-2023)
Table 41. Global Hormonal Transdermal Patches Sales Share by Application (2024-2029)
Table 42. Global Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Hormonal Transdermal Patches Revenue Share by Application (2018-2023)
Table 45. Global Hormonal Transdermal Patches Revenue Share by Application (2024-2029)
Table 46. Hormonal Transdermal Patches Price by Application (2018-2023) & (US$/Unit)
Table 47. Global Hormonal Transdermal Patches Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Hormonal Transdermal Patches Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Hormonal Transdermal Patches Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada Hormonal Transdermal Patches Sales by Country (2024-2029) & (K Units)
Table 61. Europe Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 62. Europe Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 63. Europe Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 66. Europe Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 67. Europe Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Hormonal Transdermal Patches Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Hormonal Transdermal Patches Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 73. Europe Hormonal Transdermal Patches Sales by Country (2024-2029) & (K Units)
Table 74. China Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 75. China Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 76. China Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 79. China Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 80. China Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 83. Asia Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 84. Asia Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 87. Asia Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 88. Asia Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Hormonal Transdermal Patches Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Hormonal Transdermal Patches Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Hormonal Transdermal Patches Sales by Region (2018-2023) & (K Units)
Table 94. Asia Hormonal Transdermal Patches Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country (2024-2029) & (K Units)
Table 108. Xulane Company Information
Table 109. Xulane Description and Major Businesses
Table 110. Xulane Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Xulane Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Xulane Recent Developments
Table 113. Twirla Company Information
Table 114. Twirla Description and Major Businesses
Table 115. Twirla Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Twirla Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Twirla Recent Developments
Table 118. Planned Parenthood Company Information
Table 119. Planned Parenthood Description and Major Businesses
Table 120. Planned Parenthood Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Planned Parenthood Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Planned Parenthood Recent Developments
Table 123. Lvye Pharma Company Information
Table 124. Lvye Pharma Description and Major Businesses
Table 125. Lvye Pharma Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Lvye Pharma Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Lvye Pharma Recent Developments
Table 128. Novartis Company Information
Table 129. Novartis Description and Major Businesses
Table 130. Novartis Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Novartis Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Novartis Recent Developments
Table 133. Bayer Healthcare Pharmaceuticals Company Information
Table 134. Bayer Healthcare Pharmaceuticals Description and Major Businesses
Table 135. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Bayer Healthcare Pharmaceuticals Recent Developments
Table 138. Watson Labs Company Information
Table 139. Watson Labs Description and Major Businesses
Table 140. Watson Labs Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Watson Labs Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Watson Labs Recent Developments
Table 143. Women First Healthcare Inc Company Information
Table 144. Women First Healthcare Inc Description and Major Businesses
Table 145. Women First Healthcare Inc Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Women First Healthcare Inc Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Women First Healthcare Inc Recent Developments
Table 148. Noven Company Information
Table 149. Noven Description and Major Businesses
Table 150. Noven Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Noven Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Noven Recent Developments
Table 153. AbbVie Company Information
Table 154. AbbVie Description and Major Businesses
Table 155. AbbVie Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. AbbVie Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. AbbVie Recent Developments
Table 158. Lumara Health Company Information
Table 159. Lumara Health Description and Major Businesses
Table 160. Lumara Health Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Lumara Health Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Lumara Health Recent Developments
Table 163. ANI Pharmaceuticals Company Information
Table 164. ANI Pharmaceuticals Description and Major Businesses
Table 165. ANI Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. ANI Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. ANI Pharmaceuticals Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Hormonal Transdermal Patches Distributors List
Table 171. Hormonal Transdermal Patches Customers List
Table 172. Hormonal Transdermal Patches Market Trends
Table 173. Hormonal Transdermal Patches Market Drivers
Table 174. Hormonal Transdermal Patches Market Challenges
Table 175. Hormonal Transdermal Patches Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
Table 1. Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Contraceptive Patches
Table 3. Major Manufacturers of Estradiol Patches
Table 4. Major Manufacturers of Others
Table 5. Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Hormonal Transdermal Patches Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Hormonal Transdermal Patches Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Hormonal Transdermal Patches Revenue Market Share by Region (2018-2023)
Table 10. Global Hormonal Transdermal Patches Revenue Market Share by Region (2024-2029)
Table 11. Global Hormonal Transdermal Patches Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Hormonal Transdermal Patches Sales by Region (2018-2023) & (K Units)
Table 13. Global Hormonal Transdermal Patches Sales by Region (2024-2029) & (K Units)
Table 14. Global Hormonal Transdermal Patches Sales Market Share by Region (2018-2023)
Table 15. Global Hormonal Transdermal Patches Sales Market Share by Region (2024-2029)
Table 16. Global Hormonal Transdermal Patches Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global Hormonal Transdermal Patches Sales Share by Manufacturers (2018-2023)
Table 18. Global Hormonal Transdermal Patches Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Hormonal Transdermal Patches Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Hormonal Transdermal Patches, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Hormonal Transdermal Patches Price by Manufacturers 2018-2023 (US$/Unit)
Table 22. Global Hormonal Transdermal Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Hormonal Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Transdermal Patches as of 2022)
Table 24. Global Key Manufacturers of Hormonal Transdermal Patches, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Hormonal Transdermal Patches, Product Offered and Application
Table 26. Global Key Manufacturers of Hormonal Transdermal Patches, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 29. Global Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 30. Global Hormonal Transdermal Patches Sales Share by Type (2018-2023)
Table 31. Global Hormonal Transdermal Patches Sales Share by Type (2024-2029)
Table 32. Global Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Hormonal Transdermal Patches Revenue Share by Type (2018-2023)
Table 35. Global Hormonal Transdermal Patches Revenue Share by Type (2024-2029)
Table 36. Hormonal Transdermal Patches Price by Type (2018-2023) & (US$/Unit)
Table 37. Global Hormonal Transdermal Patches Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 39. Global Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 40. Global Hormonal Transdermal Patches Sales Share by Application (2018-2023)
Table 41. Global Hormonal Transdermal Patches Sales Share by Application (2024-2029)
Table 42. Global Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Hormonal Transdermal Patches Revenue Share by Application (2018-2023)
Table 45. Global Hormonal Transdermal Patches Revenue Share by Application (2024-2029)
Table 46. Hormonal Transdermal Patches Price by Application (2018-2023) & (US$/Unit)
Table 47. Global Hormonal Transdermal Patches Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Hormonal Transdermal Patches Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Hormonal Transdermal Patches Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada Hormonal Transdermal Patches Sales by Country (2024-2029) & (K Units)
Table 61. Europe Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 62. Europe Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 63. Europe Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 66. Europe Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 67. Europe Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Hormonal Transdermal Patches Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Hormonal Transdermal Patches Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 73. Europe Hormonal Transdermal Patches Sales by Country (2024-2029) & (K Units)
Table 74. China Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 75. China Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 76. China Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 79. China Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 80. China Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 83. Asia Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 84. Asia Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 87. Asia Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 88. Asia Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Hormonal Transdermal Patches Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Hormonal Transdermal Patches Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Hormonal Transdermal Patches Sales by Region (2018-2023) & (K Units)
Table 94. Asia Hormonal Transdermal Patches Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales by Country (2024-2029) & (K Units)
Table 108. Xulane Company Information
Table 109. Xulane Description and Major Businesses
Table 110. Xulane Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Xulane Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Xulane Recent Developments
Table 113. Twirla Company Information
Table 114. Twirla Description and Major Businesses
Table 115. Twirla Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Twirla Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Twirla Recent Developments
Table 118. Planned Parenthood Company Information
Table 119. Planned Parenthood Description and Major Businesses
Table 120. Planned Parenthood Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Planned Parenthood Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Planned Parenthood Recent Developments
Table 123. Lvye Pharma Company Information
Table 124. Lvye Pharma Description and Major Businesses
Table 125. Lvye Pharma Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Lvye Pharma Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Lvye Pharma Recent Developments
Table 128. Novartis Company Information
Table 129. Novartis Description and Major Businesses
Table 130. Novartis Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Novartis Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Novartis Recent Developments
Table 133. Bayer Healthcare Pharmaceuticals Company Information
Table 134. Bayer Healthcare Pharmaceuticals Description and Major Businesses
Table 135. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Bayer Healthcare Pharmaceuticals Recent Developments
Table 138. Watson Labs Company Information
Table 139. Watson Labs Description and Major Businesses
Table 140. Watson Labs Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Watson Labs Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Watson Labs Recent Developments
Table 143. Women First Healthcare Inc Company Information
Table 144. Women First Healthcare Inc Description and Major Businesses
Table 145. Women First Healthcare Inc Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Women First Healthcare Inc Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Women First Healthcare Inc Recent Developments
Table 148. Noven Company Information
Table 149. Noven Description and Major Businesses
Table 150. Noven Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Noven Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Noven Recent Developments
Table 153. AbbVie Company Information
Table 154. AbbVie Description and Major Businesses
Table 155. AbbVie Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. AbbVie Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. AbbVie Recent Developments
Table 158. Lumara Health Company Information
Table 159. Lumara Health Description and Major Businesses
Table 160. Lumara Health Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Lumara Health Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Lumara Health Recent Developments
Table 163. ANI Pharmaceuticals Company Information
Table 164. ANI Pharmaceuticals Description and Major Businesses
Table 165. ANI Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. ANI Pharmaceuticals Hormonal Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. ANI Pharmaceuticals Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Hormonal Transdermal Patches Distributors List
Table 171. Hormonal Transdermal Patches Customers List
Table 172. Hormonal Transdermal Patches Market Trends
Table 173. Hormonal Transdermal Patches Market Drivers
Table 174. Hormonal Transdermal Patches Market Challenges
Table 175. Hormonal Transdermal Patches Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Hormonal Transdermal Patches Product Picture
Figure 2. Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hormonal Transdermal Patches Market Share by Type in 2022 & 2029
Figure 4. Contraceptive Patches Product Picture
Figure 5. Estradiol Patches Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Hormonal Transdermal Patches Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Hormonal Transdermal Patches Report Years Considered
Figure 12. Global Hormonal Transdermal Patches Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Hormonal Transdermal Patches Revenue 2018-2029 (US$ Million)
Figure 14. Global Hormonal Transdermal Patches Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Hormonal Transdermal Patches Revenue Market Share by Region (2018-2029)
Figure 16. Global Hormonal Transdermal Patches Sales 2018-2029 ((K Units)
Figure 17. Global Hormonal Transdermal Patches Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 23. China Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Hormonal Transdermal Patches Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Hormonal Transdermal Patches in the World: Market Share by Hormonal Transdermal Patches Revenue in 2022
Figure 30. Global Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 32. Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 33. Global Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 34. Global Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Hormonal Transdermal Patches Revenue Share by Country (2018-2029)
Figure 40. US & Canada Hormonal Transdermal Patches Sales Share by Country (2018-2029)
Figure 41. U.S. Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 44. Europe Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 45. Europe Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 46. Europe Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 47. Europe Hormonal Transdermal Patches Revenue Share by Country (2018-2029)
Figure 48. Europe Hormonal Transdermal Patches Sales Share by Country (2018-2029)
Figure 49. Germany Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 50. France Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 54. China Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 55. China Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 56. China Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 57. China Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 58. Asia Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 59. Asia Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 60. Asia Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 61. Asia Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 62. Asia Hormonal Transdermal Patches Revenue Share by Region (2018-2029)
Figure 63. Asia Hormonal Transdermal Patches Sales Share by Region (2018-2029)
Figure 64. Japan Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 68. India Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales Share by Country (2018-2029)
Figure 75. Brazil Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 80. Hormonal Transdermal Patches Value Chain
Figure 81. Hormonal Transdermal Patches Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Figure 1. Hormonal Transdermal Patches Product Picture
Figure 2. Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hormonal Transdermal Patches Market Share by Type in 2022 & 2029
Figure 4. Contraceptive Patches Product Picture
Figure 5. Estradiol Patches Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Hormonal Transdermal Patches Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Hormonal Transdermal Patches Report Years Considered
Figure 12. Global Hormonal Transdermal Patches Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Hormonal Transdermal Patches Revenue 2018-2029 (US$ Million)
Figure 14. Global Hormonal Transdermal Patches Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Hormonal Transdermal Patches Revenue Market Share by Region (2018-2029)
Figure 16. Global Hormonal Transdermal Patches Sales 2018-2029 ((K Units)
Figure 17. Global Hormonal Transdermal Patches Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 23. China Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Hormonal Transdermal Patches Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Hormonal Transdermal Patches in the World: Market Share by Hormonal Transdermal Patches Revenue in 2022
Figure 30. Global Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 32. Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 33. Global Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 34. Global Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Hormonal Transdermal Patches Revenue Share by Country (2018-2029)
Figure 40. US & Canada Hormonal Transdermal Patches Sales Share by Country (2018-2029)
Figure 41. U.S. Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 44. Europe Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 45. Europe Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 46. Europe Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 47. Europe Hormonal Transdermal Patches Revenue Share by Country (2018-2029)
Figure 48. Europe Hormonal Transdermal Patches Sales Share by Country (2018-2029)
Figure 49. Germany Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 50. France Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 54. China Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 55. China Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 56. China Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 57. China Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 58. Asia Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 59. Asia Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 60. Asia Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 61. Asia Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 62. Asia Hormonal Transdermal Patches Revenue Share by Region (2018-2029)
Figure 63. Asia Hormonal Transdermal Patches Sales Share by Region (2018-2029)
Figure 64. Japan Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 68. India Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Hormonal Transdermal Patches Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Hormonal Transdermal Patches Sales Share by Country (2018-2029)
Figure 75. Brazil Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Hormonal Transdermal Patches Revenue (2018-2029) & (US$ Million)
Figure 80. Hormonal Transdermal Patches Value Chain
Figure 81. Hormonal Transdermal Patches Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
